Results 21 to 30 of about 1,148,813 (206)

Effect of rifaximin in the prevention of acute kidney injury and hepatorenal syndrome type II in Egyptian cirrhotic patients [PDF]

Zagazig University Medical Journal, 2021
Background: Hepatorenal syndrome type II and acute kidney injury found in 20% of cirrhotic patients. Rifaximin was found to reduce the frequency of hepatorenal syndrome type II and acute kidney injury in alcohol cirrhotic patients.
Ahmed El-Gebaly, Nermin Ghanem, Ahmed Abdelmoaty   +2 more
doaj   +1 more source

Diagnostic and prognostic performance of urinary neutrophil gelatinase‐associated lipocalin in patients with cirrhosis and acute kidney injury

Hepatology, EarlyView., 2022
Diagnostic and prognostic ability of urinary NGAL in patients with cirrhosis and AKI. Abstract Background and Aims Acute kidney injury (AKI) commonly occurs in patients with decompensated cirrhosis. Urinary neutrophil gelatinase–associated lipocalin (uNGAL) could help discriminate between different etiologies of AKI.
Carmine Gambino, Salvatore Piano, Matteo Stenico, Marta Tonon, Alessandra Brocca, Valeria Calvino, Simone Incicco, Nicola Zeni, Roberta Gagliardi, Chiara Cosma, Martina Zaninotto, Patrizia Burra, Umberto Cillo, Daniela Basso, Paolo Angeli   +14 more
wiley   +1 more source

Factors associated with cardiovascular events after simultaneous liver–kidney transplant from the US Multicenter Simultaneous Liver–Kidney Transplant Consortium

Hepatology Communications, EarlyView., 2022
Abstract Cardiovascular disease is a leading complication after both liver and kidney transplantation. Factors associated with and rates of cardiovascular events (CVEs) after simultaneous liver–kidney transplant (SLKT) are unknown. This was a retrospective cohort study of adult SLKT recipients between 2002 and 2017 at six centers in six United Network ...
Jennifer Jo, Gonzalo Crespo, Dyanna Gregory, Jasmine Sinha, Jiaheng Xie, Min Zhang, John Magee, Pranab Barman, Yuval A. Patel, Aaron Schluger, Kara Walters, Scott Biggins, Natalia Filipek, Giuseppe Cullaro, Randi Wong, Jennifer C. Lai, Gabriel J. Perreault, Elizabeth C. Verna, Pratima Sharma, Lisa B. VanWagner   +19 more
wiley   +1 more source

Hepatorenal syndrome: pathophysiology, diagnosis, and management [PDF]

, 2021
Hepatorenal syndrome (HRS), the extreme manifestation of renal impairment in patients with cirrhosis, is characterized by reduction in renal blood flow and glomerular filtration rate.
Ginès i Gibert, Pere, Kamath, Patrick S., Simonetto, Douglas A.   +2 more
core   +1 more source

TERLIPRESSIN VERSUS NOREPINEPHRIN IN MANAGEMENT OF TYPE 1 HEPATORENAL SYNDROME PATIENTS [PDF]

Ain Shams Medical Journal, 2023
Background: Cirrhosis affects millions of people throughout the world. Patients with cirrhosis frequently develop renal failure. Hepatorenal syndrome (HRS) develops in decompensated liver disease and it is considered to be the most severe complication ...
Rasha Fathallah, Sherif Nashed, Adel El-Ansary, Ahmed Yousef   +3 more
doaj   +1 more source

The hepatorenal syndrome

Gastroenterology, 1979
The patient was a 45-yr-old alcoholic white male admitted to the Albany Medical Center Hospital (AMCH) because of increasing jaundice, dark urine, light stools, and ascites of 4 mo duration. He had been a heavy drinker for the past 15 yr. One year before admission he noted easy bruising, epistaxis, and intermittent vague abdominal discomfort.
P Y, Wong, G C, McCoy, A, Spielberg, R V, Milora, J A, Balint   +4 more
openaire   +2 more sources

Necessity and feasibility of developing diagnosis and treatment guidelines for  cirrhotic ascites and hepatorenal syndrome with Chinese intellectual property rights

Zhongguo linchuang yanjiu, 2023
At pressent, there are many controversies in China about the recommendations in Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome (hereinafter referred to as the “Guidelines”) revised in 2021 ...
LIU Jianjun, ZHENG Wenkai, GAO Tingting, WANG Jianghong, REN Yanjun, LIU Jianguo, LIU Changlin   +6 more
doaj   +1 more source

Low doses of terlipressin and albumin in the type I hepatorenal syndrome

Italian Journal of Medicine, 2013
BACKGROUND Hepatorenal syndrome is a pre-renal like dysfunction that generally onsets in cirrhotic patients presenting ascites. MATERIALS AND METHODS We investigated the improvement of renal function in subjects with hepatorenal syndrome after ...
Davide Pulvirenti, Aikaterini Tsami
doaj   +1 more source

Population Based Trends in the Incidence of Hospital Admission for the Diagnosis of Hepatorenal Syndrome: 1998–2011

International Journal of Nephrology, 2016
Background and Objectives. Hepatorenal syndrome carries a high risk of mortality. Understanding the incidence and mortality trends in hepatorenal syndrome will help inform future studies regarding the safety and efficacy of potential therapeutic ...
Manish Suneja, Fan Tang, Joseph E. Cavanaugh, Linnea A. Polgreen, Philip M. Polgreen   +4 more
doaj   +1 more source

HEPATORENAL SYNDROME WITH ACUTE RENAL FAILURE IN PATIENTS WITH CHRONIC LIVER DISEASE: MODERN ASPECTS OF CLINICAL PRESENTATION AND INTENSIVE CARE

Креативная хирургия и онкология, 2018
Introduction. Acute renal failure is considered a functional, progressive, oliguric, but reversible kidney disease that occurs due to severe liver disease with hepatic insufficiency.
R. R. Nagimullin, F. A. Shipulin, A. Zh. Bayalieva   +2 more
doaj   +1 more source